# MOSAIC CO (MOS)

Informational only - not investment advice.

CIK: 0001285785
SIC: 2870 Agricultural Chemicals
SIC breadcrumb: [Manufacturing](/division/D/) > [Chemicals And Allied Products](/major-group/28/) > [SIC 2870 Agricultural Chemicals](/industry/2870/)
Latest 10-K filed: 2026-02-27
SEC page: https://www.sec.gov/edgar/browse/?CIK=1285785
Filing source: https://www.sec.gov/Archives/edgar/data/1285785/000128578526000017/mos-20251231.htm

## At a glance

FY2025 · period end 2025-12-31 · filed 2026-02-27 · accession 0001285785-26-000017 · source: https://data.sec.gov/api/xbrl/companyfacts/CIK0001285785.json

| Metric | Value | FY | Provenance |
| --- | ---: | ---: | --- |
| Revenue | 12,052,400,000 USD | 2025 | verified |
| Net income | 540,700,000 USD | 2025 | verified |
| Assets | 24,480,100,000 USD | 2025 | verified |
| Free cash flow | -534,600,000 USD | 2025 | computed |
| Net margin | 4.49% | 2025 | computed |
| Operating margin | 6.82% | 2025 | computed |
| Revenue YoY | +8.36% | 2025 | computed |
| ROE | 4.47% | 2025 | computed |

Computed values are grepcent-computed from the verified facts above and may differ from ratios the company itself reports. Free cash flow = operating cash flow − capital expenditures. Net margin = net income ÷ revenue. Operating margin = operating income ÷ revenue. Revenue YoY = FY2025 revenue ÷ FY2024 revenue − 1 (consecutive fiscal years only). ROE = net income ÷ period-end stockholders' equity.

No market price, no rating, no forecast on this site. Not investment advice.

### Peer percentile fingerprint

| Ratio | MOS | Peer median | Percentile | N |
| --- | ---: | ---: | ---: | ---: |
| Net margin | 4.5% | 1.2% | 57 | 219 |
| Operating margin | 6.8% | 3.0% | 57 | 201 |
| Revenue growth | 8.4% | 8.0% | 51 | 251 |
| FCF margin | -4.4% | -1.7% | 46 | 251 |
| ROE | 4.5% | -23.2% | 72 | 314 |
| ROA | 2.2% | -12.1% | 72 | 340 |
| Liabilities / equity | 1.03 | 0.61 | 61 | 319 |
| Current ratio | 1.32 | 3.93 | 9 | 341 |

Percentile = share of the N covered peers reporting that ratio whose value is lower (ties counted half); computed among grepcent-covered companies in SIC major-group 28 Chemicals And Allied Products, not the whole market. A higher percentile means a higher value of the ratio, not a better company. Ratios with fewer than 8 reporting peers are omitted. Latest reported values per company; fiscal periods may differ. Descriptive arithmetic - not a score, rating, or ranking.

## Selected Fundamentals
| Metric | Value | Unit | FY | Filed |
| --- | ---: | --- | ---: | --- |
| Revenue | 12052400000 | USD | 2025 | 2026-02-27 |
| Net income | 540700000 | USD | 2025 | 2026-02-27 |
| Assets | 24480100000 | USD | 2025 | 2026-02-27 |

## Financials

Annual standardized facts from SEC companyfacts as of latest extracted filing date 2026-02-27. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0001285785.json. Derived margins, ratios, and free cash flow are computed from the extracted annual SEC facts.

| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue |  |  | 9,587,300,000 | 8,906,300,000 | 8,681,700,000 | 12,357,400,000 | 19,125,200,000 | 13,696,100,000 | 11,122,800,000 | 12,052,400,000 |
| Net income | 297,800,000 | -107,200,000 | 470,000,000 | -1,067,400,000 | 666,100,000 | 1,630,600,000 | 3,582,800,000 | 1,164,900,000 | 174,900,000 | 540,700,000 |
| Operating income | 319,000,000 | 465,700,000 | 928,300,000 | -1,094,900,000 | 412,900,000 | 2,468,500,000 | 4,785,300,000 | 1,338,100,000 | 621,500,000 | 821,500,000 |
| Gross profit | 810,000,000 | 842,800,000 | 1,498,400,000 | 897,300,000 | 1,064,900,000 | 3,200,300,000 | 5,755,800,000 | 2,210,600,000 | 1,511,900,000 | 1,901,900,000 |
| Diluted EPS | 0.85 | -0.31 | 1.22 | -2.78 | 1.75 | 4.27 | 10.06 | 3.50 | 0.55 | 1.70 |
| Operating cash flow | 1,260,200,000 | 935,500,000 | 1,409,800,000 | 1,095,400,000 | 1,582,600,000 | 2,187,000,000 | 3,935,800,000 | 2,407,200,000 | 1,299,200,000 | 824,800,000 |
| Capital expenditures | 843,100,000 | 820,100,000 | 954,500,000 | 1,272,200,000 | 1,170,600,000 | 1,288,600,000 | 1,247,300,000 | 1,402,400,000 | 1,251,800,000 | 1,359,400,000 |
| Dividends paid | 385,100,000 | 210,600,000 | 38,500,000 | 67,200,000 | 75,800,000 | 103,700,000 | 197,700,000 | 351,600,000 | 270,700,000 | 280,400,000 |
| Share buybacks | 75,000,000 | 0.00 | 0.00 | 149,900,000 | 0.00 | 410,900,000 | 1,665,200,000 | 756,000,000 | 235,400,000 | 0.00 |
| Assets | 16,840,700,000 | 18,633,400,000 | 20,119,200,000 | 19,298,500,000 | 19,789,800,000 | 22,036,400,000 | 23,386,000,000 | 23,032,800,000 | 22,924,000,000 | 24,480,100,000 |
| Stockholders' equity | 9,584,600,000 | 9,617,500,000 | 10,397,300,000 | 9,185,500,000 | 9,581,400,000 | 10,604,100,000 | 12,054,600,000 | 12,290,200,000 | 11,482,400,000 | 12,084,900,000 |
| Cash and cash equivalents | 673,100,000 | 2,153,500,000 | 847,700,000 | 519,100,000 | 574,000,000 | 769,500,000 | 735,400,000 | 348,800,000 | 272,800,000 | 276,600,000 |
| Free cash flow | 417,100,000 | 115,400,000 | 455,300,000 | -176,800,000 | 412,000,000 | 898,400,000 | 2,688,500,000 | 1,004,800,000 | 47,400,000 | -534,600,000 |

### Ratios

ROE and ROA use period-end equity/assets. Liabilities / equity uses total liabilities divided by stockholders' equity. Current ratio uses current assets divided by current liabilities when both are reported.

| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Net margin |  |  | 4.90% | -11.98% | 7.67% | 13.20% | 18.73% | 8.51% | 1.57% | 4.49% |
| Operating margin |  |  | 9.68% | -12.29% | 4.76% | 19.98% | 25.02% | 9.77% | 5.59% | 6.82% |
| Return on equity | 3.11% | -1.11% | 4.52% | -11.62% | 6.95% | 15.38% | 29.72% | 9.48% | 1.52% | 4.47% |
| Return on assets | 1.77% | -0.58% | 2.34% | -5.53% | 3.37% | 7.40% | 15.32% | 5.06% | 0.76% | 2.21% |
| Liabilities / equity | 0.76 | 0.94 | 0.94 | 1.10 | 1.07 | 1.08 | 0.94 | 0.87 | 1.00 | 1.03 |
| Current ratio | 2.07 | 2.27 | 1.71 | 1.43 | 1.12 | 1.11 | 1.18 | 1.22 | 1.08 | 1.32 |

## As-reported value updates

No tracked differences above grepcent's stated thresholds and capped precision rule were found between the earliest XBRL-filed value and the value currently on file for the standardized annual metrics grepcent tracks.


## Quarterly

Quarterly standardized facts from SEC companyfacts as of latest extracted filing date 2026-08-05. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0001285785.json.

Flow metrics use discrete quarter-length periods from 10-Q/10-Q/A filings. Q4 revenue and net income are derived only when annual FY and nine-month YTD facts exist for the same fiscal year; derived Q4 values are labeled. EPS Q4 is not derived.

| Quarter | End date | Revenue | Net income | Diluted EPS | Method |
| --- | --- | ---: | ---: | ---: | --- |
| 2022-Q3 | 2022-09-30 |  |  | 2.42 | reported discrete quarter |
| 2023-Q1 | 2023-03-31 |  |  | 1.28 | reported discrete quarter |
| 2023-Q2 | 2023-06-30 |  |  | 1.11 | reported discrete quarter |
| 2023-Q3 | 2023-09-30 | 3,548,300,000 | -4,200,000 | -0.01 | reported discrete quarter |
| 2023-Q4 | 2023-12-31 | 3,149,500,000 | 365,300,000 |  | derived Q4 = FY annual - nine-month YTD |
| 2024-Q1 | 2024-03-31 | 2,679,400,000 | 45,200,000 | 0.14 | reported discrete quarter |
| 2024-Q2 | 2024-06-30 | 2,816,600,000 | -161,500,000 | -0.50 | reported discrete quarter |
| 2024-Q3 | 2024-09-30 | 2,810,900,000 | 122,200,000 | 0.38 | reported discrete quarter |
| 2024-Q4 | 2024-12-31 | 2,815,900,000 | 169,000,000 |  | derived Q4 = FY annual - nine-month YTD |
| 2025-Q1 | 2025-03-31 | 2,620,900,000 | 238,100,000 | 0.75 | reported discrete quarter |
| 2025-Q2 | 2025-06-30 | 3,005,700,000 | 410,700,000 | 1.29 | reported discrete quarter |
| 2025-Q3 | 2025-09-30 | 3,452,100,000 | 411,400,000 | 1.29 | reported discrete quarter |
| 2025-Q4 | 2025-12-31 | 2,973,700,000 | -519,500,000 |  | derived Q4 = FY annual - nine-month YTD |
| 2026-Q1 | 2026-03-31 | 2,998,000,000 | -257,600,000 | -0.81 | reported discrete quarter |
| 2026-Q2 | 2026-06-30 | 2,824,100,000 | -272,800,000 | -0.86 | reported discrete quarter |

## Filed narrative (10-K & 10-Q)

## Business

Verbatim Item 1 Business section from MOS's latest 10-K: [/company/MOS/business/](/company/MOS/business/).

## Risk Factors

Verbatim Item 1A Risk Factors from MOS's latest 10-K: [/company/MOS/risk-factors/](/company/MOS/risk-factors/).

## Latest quarter (10-Q)

Latest 10-Q source: https://www.sec.gov/Archives/edgar/data/1285785/000128578526000112/mos-20260630.htm

Extracted from a substantive MD&A body after the formal Item 2 span was a TOC or reference stub.
Confidence: high
Filing date: 2026-08-05
Report date: 2026-06-30

Results of Operations

The following table shows the results of operations for the three and six months ended June 30, 2026 and June 30, 2025:

[[GREPCENT_TABLE]]
[["","Three months ended","","","","","","Six months ended"],["","June 30,","","2026-2025","","June 30,","","2026-2025"],["(in millions, except per share data)","2026","","2025","","Change","","Percent","","2026","","2025","","Change","","Percent"],["Net sales","$","2,824.1","","","$","3,005.7","","","$","(181.6)","","","(6)","%","","$","5,822.1","","","$","5,626.6","","","$","195.5","","","3","%"],["Cost of goods sold","2,609.4","","","2,487.1","","","122.3","","","5","%","","5,371.8","","","4,619.6","","","752.2","","","16","%"],["Gross margin","214.7","","518.6","","(303.9)","","","(59)","%","","450.3","","1,007.0","","(556.7)","","","(55)","%"],["Gross margin percentage","8%","","17%","","(9)","%","","","","8%","","18%"],["Selling, general and administrative expenses","131.6","","167.2","","(35.6)","","","(21)","%","","267.5","","289.8","","(22.3)","","","(8)","%"],["Loss on assets sold and to be sold","$","6.2","","\u2014","","6.2","","","NM","","$","238.8","","\u2014","","238.8","","","NM"],["Other operating expense","112.4","","107.0","","5.4","","","5","%","","352.4","","134.3","","218.1","","","162","%"],["Operating earnings (loss)","(35.5)","","244.4","","(279.9)","","","(115)","%","","(408.4)","","582.9","","(991.3)","","","NM"],["Interest expense, net","(62.8)","","(53.0)","","(9.8)","","","18","%","","(118.1)","","(93.7)","","(24.4)","","","26","%"],["Foreign currency transaction gain (loss)","(39.4)","","169.4","","(208.8)","","","NM","","(1.8)","","302.5","","(304.3)","","","(101)","%"],["Other income (expense)","(163.2)","","203.5","","(366.7)","","","(180)","%","","(58.5)","","85.4","","(143.9)","","","NM"],["Earnings (loss) from consolidated companies before income taxes","(300.9)","","564.3","","(865.2)","","","(153)","%","","(586.8)","","877.1","","(1,463.9)","","","NM"],["(Benefit) provision for income taxes","(33.8)","","146.0","","(179.8)","","","(123)","%","","(64.8)","","209.3","","(274.1)","","","NM"],["Earnings (loss) from consolidated companies","(267.1)","","418.3","","(685.4)","","","(164)","%","","(522.0)","","667.8","","(1,189.8)","","","NM"],["Equity in net earnings of nonconsolidated companies","1.6","","1.4","","0.2","","","14","%","","2.0","","1.9","","0.1","","","5","%"],["Net earnings (loss) including noncontrolling interests","(265.5)","","419.7","","(685.2)","","","(163)","%","","(520.0)","","669.7","","(1,189.7)","","","NM"],["Less: Net earnings attributable to noncontrolling interests","7.3","","9.0","","(1.7)","","","(19)","%","","10.4","","20.9","","(10.5)","","","(50)","%"],["Net earnings (loss) attributable to Mosaic","$","(272.8)","","$","410.7","","$","(683.5)","","","(166)","%","","$","(530.4)","","$","648.8","","$","(1,179.2)","","","NM"],["Diluted net earnings (loss) per share attributable to Mosaic","$","(0.86)","","$","1.29","","$","(2.15)","","","(167)","%","","$","(1.67)","","$","2.04","","$","(3.71)","","","NM"],["Diluted weighted average number of shares outstanding","317.9","","319.0","","","","","","317.7","","318.5"]]
[[/GREPCENT_TABLE]]

Overview of Consolidated Results for the three months ended June 30, 2026 and 2025

For the three months ended June 30, 2026, Mosaic incurred a net loss of $272.8 million, or $(0.86) per diluted share, compared to net income of $410.7 million, or $1.29 per diluted share, for the same period last year. Gross margin for the current year

29

Table of Contents

period was unfavorably impacted by higher raw material and input costs, as well as reduced sales volumes, driven largely by increased sulfur prices and supply constraints in the current period as discussed further below. During the quarter we recorded charges of approximately $69 million related to engineering and equipment costs associated with the decision not to proceed with a project based on finalization of assessments during this quarter. Pre-tax earnings (loss) for the three months ended June 30, 2026 was also negatively impacted by a foreign currency transaction loss of $39.4 million and an unrealized mark-to-market loss of approximately $161.6 million on the investment in Ma’aden shares, included in other income (expense).

Significant factors affecting our results of operations and financial condition are listed below. Certain of these factors are discussed in more detail in the following sections of this Management’s Discussion and Analysis of Financial Condition and Results of Operations.

In 2026, geopolitical events continue to drive volatility throughout global commodity markets. The continued conflict in the Middle East and attacks on the Russian and Ukraine commodities industrial assets have restricted exports of fertilizers and raw materials (namely sulfur and ammonia), further tightening global supplies, driving input costs higher and pressuring affordability of fertilizer products. While average selling prices increased in the current year periods, compared to the prior year, the increases were more than offset by elevated input costs, particularly sulfur and ammonia, which pressured margins and limited the benefit of higher selling prices.

In our Phosphate segment, the operating loss for the three months ended June 30, 2026 was $104 million compared to an operating loss of $8 million in the prior year period. In the current year period, operating results were negatively impacted by higher raw material costs of sulfur, ammonia and blended rock, compared to the prior year period. The increased raw materials costs reflect the tightened global supply conditions mentioned above. Operating results were also unfavorably impacted by decreased sales volumes, driven by affordability challenges weakening global demand. The unfavorable impact of increased costs was partially offset by favorable sales prices in the current year period driven by tight global supply conditions. In response to market conditions in the current year period, we made the decision to temporarily curtail production at certain facilities. Phosphate operating results in the current year period were also unfavorably impacted by the project write-off discussed above.

In our Potash segment, operating earnings for the three months ended June 30, 2026 were $196 million, compared to $194 million in the prior year. Operating results benefited from higher average selling prices, which have increased due to ongoing global supply challenges. This benefit was mostly offset by reduced sales volumes, which were driven by lower product availability resulting from lower production at our Esterhazy, Saskatchewan mine and the sale of our Carlsbad, New Mexico facility We closed on the sale of this facility in April of the current year.

In our Mosaic Fertilizantes segment, the operating loss for the three months ended June 30, 2026 was $41 million, compared to operating earnings of $109 million in the prior year. The decrease was primarily driven by lower sales volumes, reflecting reduced production resulting from constrained raw material availability and limited customer credit availability in Brazil during the current-year period. During the current-year period, we temporarily curtailed production at certain facilities in response to market conditions. Operating results were also adversely affected by higher costs of purchased products for resale, increased raw material costs, primarily sulfur, and higher idle costs associated with production curtailments. These unfavorable impacts were partially offset by higher average selling prices in the current-year period, reflecting tight global supply conditions.

Corporate, Eliminations and Other had an operating loss of $86 million for the three months ended June 30, 2026, compared to a loss of $51 million in the prior year. Corporate, Eliminations and Other includes the results of the China and India distribution businesses, the Mosaic Bioscience business (other than Brazil), intersegment eliminations, including profit on intersegment sales, unrealized mark-to-market gains and unrealized losses on derivatives and debt expenses.

Other Business Developments:

•On April 30, 2026, we completed the sale of our Carlsbad potash mine in New Mexico for a total purchase price $20 million, subject to adjustment, along with a deferred payment of $10 million payable in three installments from 2029 to 2031. Upon completion of the transaction, we received cash proceeds of approximately $2 million along with the deferred payment of $10 million and recognized an additional impairment loss of $6.2 million in the second quarter of 2026.

30

•In response to current market conditions and limited sulfur supply, in the third quarter of 2026 we are taking and may continue to take steps to temporarily curtail additional production at our phosphate production facilities in North America and Brazil, and blending units in Brazil.

Overview of Consolidated Results for the six months ended June 30, 2026 and 2025

For the six months ended June 30, 2026, Mosaic incurred a net loss of $530.4 million, or $(1.67) per diluted share, compared to net income of $648.8 million, or $2.04 per diluted share, for the same period a year ago. Gross margin for the three months ended June 30, 2026 decreased 55% compared to the same period of the prior year. This result was primarily driven by higher raw material and input costs, as well as reduced sales volumes, driven largely by increased sulfur prices and supply constraints in the current period as discussed above in the three-month discussion and reduced sales volumes, reflecting product availability constraints and continued affordability challenges. Net income for the six months ended June 30, 2026, was also negatively impacted by the strategic decision to idle and divest the Araxá mining and chemical complex and idle the related mining activities at the Patrocínio complex in Brazil, which resulted in additional expense of approximately $482 million. Net income was also impacted by an unrealized mark-to-market loss of $49.2 million on the investment in Ma’aden shares, included in other income (expense).

Results for the six months ended June 30, 2026 reflected the factors discussed above in the discussion for the three months ended June 30, 2026, in addition to those noted below. Certain of these factors are discussed in more detail in the following sections of this Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Operating results in our Phosphate segment for the six months ended June 30, 2026 declined from the prior year. Higher input costs of sulfur, ammonia and blended rock, drove the unfavorable impact to lower segment earnings in the current year period. The unfavorable impact of higher costs in the current year period was partially offset by favorable sales prices and increased sales volumes, reflecting increased global demand and stronger starting inventories that enabled fulfillment of export demand in the first quarter of 2026. Results also reflect the unfavorable impact of the project write-off mentioned above in the three-month discussion.

Operating results in our Potash segment for the six months ended June 30, 2026 were slightly higher than the prior year period. Higher average selling prices driven by global supply conditions favorably impacted current year results. Lower sales volumes, driven by lower product availability, partially offset this benefit.

For the six months ended June 30, 2026, operating results in our Mosaic Fertilizantes segment were unfavorable compared to the same period in the prior year. As mentioned above, in March 2026 we committed to a plan to divest of the Araxá mining and chemical complex and idle the related mining activities at the Patrocínio complex in Brazil. This decision resulted in an initial charge of approximately $442 million in the first quarter of

[Excerpt truncated for page length; source filing is linked above.]

## Latest 10-K MD&A (excerpt)

Latest 10-K Item 7 source: https://www.sec.gov/Archives/edgar/data/1285785/000128578526000017/mos-20251231.htm
Complete FY 2025 MD&A: /company/MOS/mda/fy2025/

Extracted from a later financial-section MD&A body after the formal Item 7 span was a short reference.
Confidence: high
Filing date: 2026-02-27
Report date: 2025-12-31

Management’s Discussion and Analysis of Financial Condition and Results of Operations

Introduction

The Mosaic Company (before or after the Cargill Transaction, as defined below, “Mosaic,” and with its consolidated subsidiaries, “we,” “us,” “our” or the “Company”) is the parent company of the business that was formed through the business combination (“Combination”) of IMC Global Inc. and the Cargill Crop Nutrition fertilizer businesses of Cargill, Incorporated and its subsidiaries (collectively, “Cargill”) on October 22, 2004. In May 2011, Cargill divested its approximately 64% equity interest in us in a split-off to its stockholders and a debt exchange with certain Cargill debt holders.

We produce and market concentrated phosphate and potash crop nutrients. We conduct our business through wholly- and majority-owned subsidiaries as well as businesses in which we own less than a majority or a non-controlling interest, including consolidated variable interest entities and investments accounted for by the equity method.

We are organized into the following business segments:

•Our Phosphate business segment owns and operates mines and production facilities in Florida, which produce concentrated phosphate crop nutrients and phosphate-based animal feed ingredients, and processing plants in Louisiana, which produce concentrated phosphate crop nutrients for sale domestically and internationally. We have a 75% economic interest in the Miski Mayo Phosphate Mine (“Miski Mayo Mine”) in Peru. These results are consolidated in the Phosphate segment. Through December 24, 2024, the Phosphate segment included our 25% interest in the Ma’aden Wa’ad Al Shamal Phosphate Company (“MWSPC”), a joint venture to develop, own and operate integrated phosphate production facilities in the Kingdom of Saudi Arabia. On December 24, 2024, we exchanged our ownership of MWSPC for shares of Saudi Arabian Mining Company (“Ma’aden”). Our equity in the net earnings or losses relating to MWSPC were recognized on a one-quarter lag in our Consolidated Statements of Earnings.

•Our Potash business segment owns and operates potash mines and production facilities in Canada and the U.S. which produce potash-based crop nutrients, animal feed ingredients and industrial products. Potash sales include domestic and international sales. We are a member of Canpotex, Limited (“Canpotex”), an export association of Canadian potash producers through which we sell our Canadian potash outside the U.S. and Canada.

•Our Mosaic Fertilizantes business segment includes five phosphate rock mines and four phosphate chemical plants in Brazil. The segment also includes our distribution business in South America, which consists of sales offices, crop nutrient blending and bagging facilities, port terminals and warehouses in Brazil and Paraguay. We also have a majority interest in Fospar S.A., which owns and operates a single superphosphate granulation plant and a deep-water port and throughput warehouse terminal facility in Brazil. This segment also includes the results of Mosaic Biosciences sales in Brazil.

Intersegment eliminations, unrealized mark-to-market gains/losses on derivatives and investment in equity securities of Ma'aden, debt expenses, the results of the China and India distribution businesses and Mosaic Biosciences sales in China, India and North America are included within Corporate, Eliminations and Other. See Note 25 of the Consolidated Financial Statements in this Form 10-K for segment results.

Key Factors That Can Affect Results of Operations and Financial Condition

Our primary products, phosphate and potash crop nutrients, are, to a large extent, global commodities that are also available from a number of domestic and international competitors, and are sold by negotiated contracts or by reference to published market prices. The markets for our products are highly competitive, and the most important competitive factor for our products is delivered price. Business and economic conditions and governmental policies affecting the agricultural industry and customer sentiment are the most significant factors affecting worldwide demand for crop nutrients with the impact of demand for biofuels and batteries also playing an increasing role. The profitability of our businesses is heavily influenced by worldwide supply and demand for our products, which affects our sales prices and volumes. Our costs per tonne to produce our products are also heavily influenced by fixed costs associated with owning and operating our major facilities, significant raw material costs in our Phosphate and Mosaic Fertilizantes businesses, water treatment costs in our Phosphate business and fluctuations in currency exchange rates.

F- 2

Our products are generally sold based on the market prices prevailing at the time the sales contract is signed or through contracts which are priced at the time of shipment. Additionally, in certain circumstances the final price of our products is determined after shipment based on the current market at the time the price is agreed to with the customer. Forward sales programs at fixed prices increase the lag between prevailing market prices and our average realized selling prices. The mix and parameters of these sales programs vary over time based on our marketing strategy, which considers factors that include, among others, optimizing our production and operating efficiency within warehouse limitations, as well as customer requirements. The use of forward sales programs and the level of customer prepayments may vary from period to period due to changing supply and demand environments, seasonality and market sentiments.

World prices for the key raw material inputs for concentrated phosphate products, including ammonia, sulfur and phosphate rock, have an effect on industry-wide phosphate prices and production costs. The primary feedstock for producing ammonia is natural gas. The product price for ammonia is generally highly dependent on the supply and demand balance for ammonia. In North America, two-thirds of our ammonia is sourced either through ammonia supply agreements or produced internally at our Faustina, Louisiana, location with the remaining one-third purchased from various suppliers in the spot market. We have agreements with various suppliers to ensure we have reliable sources of supply for ammonia to support competitive pricing in various market conditions. In Brazil, we purchase all our ammonia from a single supplier.

Sulfur is a global commodity that is primarily produced as a by-product of oil refining. The market price is based primarily on the supply and demand balance for sulfur. We believe our current and future investments in sulfur transformation and transportation assets will enhance our competitive advantage.

We produce and procure most of our phosphate rock requirements through either wholly or partly owned mines. In addition to producing phosphate rock, Mosaic Fertilizantes purchases phosphate, potash and nitrogen products which are either used to produce blended crop nutrients (“Blends”) or for resale.

Our per tonne selling prices for potash are affected by shifts in the product mix, geography and customer mix. Our Potash business is significantly affected by Canadian resource taxes that we pay to the Province of Saskatchewan and royalties we pay to mineral holders in order for us to mine and sell our potash products. In addition, cost of goods sold is affected by a number of factors, including: fluctuations in the Canadian dollar; the level of periodic inflationary pressures on resources in western Canada, where we produce most of our potash; and natural gas costs for operating our potash solution mine at Belle Plaine, Saskatchewan. In the past, we have also incurred operating costs to manage salt saturated brine inflows at our Esterhazy, Saskatchewan K1 and K2 mine shafts, which we closed in June 2021, due to an acceleration of brine inflows. We have now transitioned mining to the K3 mine shaft, which has replaced production from the K1 and K2 shafts.

Our results of operations are also affected by changes in currency exchange rates due to our international footprint. The most significant currency impacts are generally from the Canadian dollar and the Brazilian real.

A discussion of these and other factors that affected our results of operations and financial condition for the periods covered by this Management’s Discussion and Analysis of Financial Condition and Results of Operations is set forth in further detail below. This Management’s Discussion and Analysis of Financial Condition and Results of Operations should also be read in conjunction with the narrative description of our business in Item 1, and the risk factors described in Item 1A, of Part I of this Annual Report on Form 10-K (“Form 10-K”), and our Consolidated Financial Statements, accompanying notes and other information listed in the accompanying Financial Table of Contents.

This section of this Form 10-K discusses 2025 and 2024 items and year-to-year comparisons between 2025 and 2024. Discussions of 2023 items and year-to-year comparisons between 2024 and 2023 that are not included in this Form 10-K can be found in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Part II, Item 7 of the Company’s Form 10-K for the year ended December 31, 2024 and are incorporated by reference herein.

Throughout the discussion below, we measure units of production, sales and raw materials in metric tonnes which are the equivalent of 2,205 pounds, unless we specifically state that we mean short or long ton(s), which are the equivalent of 2,000 pounds and 2,240 pounds, respectively. In addition, we measure natural gas, a raw material used in the production of our products, in MM BTU, which stands for one million British Thermal Units (“BTU”). One BTU is equivalent to 1.06 Joules. Management uses the following metrics to monitor segment performance: production volume, sales volume, average finished product selling price and average cost per unit consumed.

In the following table, there are certain percentages that are not considered to be meaningful and are represented by “NM”.

F- 3

Results of Operations

The following table shows the results of operations for the years ended December 31, 2025, 2024, and 2023:

[Excerpt truncated for page length; the complete text is on the linked full-MD&A page.]

Read the full FY 2025 MD&A: /company/MOS/mda/fy2025/
All MD&A years: /company/MOS/mda/


## MD&A history

Prior-year 10-K MD&A spans are extracted from SEC filings with the same bounded parser used for the latest filing. Each year's full verbatim text is on its own sub-page.

- [FY 2024 MD&A](/company/MOS/mda/fy2024/): filed 2025-03-03; accession 0001618034-25-000003 (https://www.sec.gov/Archives/edgar/data/1285785/000161803425000003/mos-20241231.htm)
- [FY 2023 MD&A](/company/MOS/mda/fy2023/): filed 2024-02-22; accession 0001618034-24-000004 (https://www.sec.gov/Archives/edgar/data/1285785/000161803424000004/mos-20231231.htm)
- [FY 2022 MD&A](/company/MOS/mda/fy2022/): filed 2023-02-23; accession 0001618034-23-000003 (https://www.sec.gov/Archives/edgar/data/1285785/000161803423000003/mos-20221231.htm)
- [FY 2021 MD&A](/company/MOS/mda/fy2021/): filed 2022-02-23; accession 0001618034-22-000004 (https://www.sec.gov/Archives/edgar/data/1285785/000161803422000004/mos-20211231.htm)




## Macro cross-references

Indicators mapped to this company's SIC classification (industry 2870 Agricultural Chemicals) by grepcent's deterministic macro-sector crosswalk. A navigational mapping, not a statistical or causal claim.

- [INDPRO](/indicator/INDPRO/): Industrial Production: Total Index
- [TCU](/indicator/TCU/): Capacity Utilization: Total Index
- [PPIACO](/indicator/PPIACO/): Producer Price Index by Commodity: All Commodities
- [GDPC1](/indicator/GDPC1/): Real Gross Domestic Product
- [DGS10](/indicator/DGS10/): Market Yield on U.S. Treasury Securities at 10-Year Constant Maturity
- [FEDFUNDS](/indicator/FEDFUNDS/): Federal Funds Effective Rate
- [CES0500000003](/indicator/CES0500000003/): Average Hourly Earnings of All Employees, Total Private
- [PAYEMS](/indicator/PAYEMS/): All Employees, Total Nonfarm

Macro-to-micro threads including this sector: [Inflation (CPI / PCE / PPI)](/thread/inflation-cpi-pce-ppi/), [US labor market](/thread/us-labor-market/), [Growth & output](/thread/growth-output/), [Money & trade](/thread/money-trade/), [Government finances](/thread/government-finances/), [Sector employment](/thread/sector-employment/), [Industrial orders & inventories](/thread/industrial-orders/), [Trade & external](/thread/trade-external/).

All macro indicators: /indicators/


## For LLMs & downloads

Markdown twin: /company/MOS.md · JSON record: /company/MOS.json · verified financials: /company/MOS/financials.json / /company/MOS/financials.csv · machine TOC for the whole site: /llms.txt